Vitro, S.A.B. de C.V.
VITOF
$0.66
-$0.01-1.49%
OTC PK
| 09/30/2024 | 12/31/2023 | 09/30/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | 1.38B | -199.27M | -199.24M | 342.68M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 1.38B | -199.27M | -199.24M | 342.68M |
| Cost of Revenue | -- | 992.58M | -290.41M | -290.35M | 140.09M |
| Gross Profit | -- | 392.04M | 91.14M | 91.11M | 202.60M |
| SG&A Expenses | -- | 289.31M | 33.49M | 33.55M | 117.16M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -2.11M | 1.59M | 1.36M | -1.53M |
| Total Operating Expenses | -- | 1.28B | -255.34M | -255.45M | 255.71M |
| Operating Income | -- | 104.84M | 56.06M | 56.20M | 86.97M |
| Income Before Tax | -- | 93.45M | 89.80M | 89.48M | 103.99M |
| Income Tax Expenses | -- | 4.35M | -1.71M | -1.82M | 26.59M |
| Earnings from Continuing Operations | -- | 89.10 | 91.50 | 91.30 | 77.40 |
| Earnings from Discontinued Operations | -- | 85.54M | 16.10M | 16.00M | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | 277.00K | 234.00K | 190.00K | 292.00K |
| Net Income | -- | 174.92M | 92.23M | 91.88M | 62.08M |
| EBIT | -- | 104.84M | 56.06M | 56.20M | 86.97M |
| EBITDA | -- | 256.68M | 178.97M | 179.11M | 207.04M |
| EPS Basic | -- | 0.39 | 0.21 | 0.21 | 0.15 |
| Normalized Basic EPS | -- | 0.13 | 0.17 | 0.17 | 0.19 |
| EPS Diluted | -- | 0.39 | 0.21 | 0.21 | 0.15 |
| Normalized Diluted EPS | -- | 0.13 | 0.17 | 0.17 | 0.19 |
| Average Basic Shares Outstanding | -- | 1.82B | 1.85B | 1.84B | 1.90B |
| Average Diluted Shares Outstanding | -- | 1.82B | 1.85B | 1.84B | 1.90B |
| Dividend Per Share | -- | -- | 0.06 | 0.06 | 0.06 |
| Payout Ratio | -- | 17.15% | 43.37% | 43.54% | 64.44% |